Analyst price target range
HealthEquity Price Target: $119.33 Average
Direct answer
HealthEquity's average price target is $119.33.
The verified analyst range runs from $105.00 to $142.00.
The low target implies +13.8%, the high target implies +53.9%, and the range spans 40.1% of the current price.
Forecast evidence checked October 7, 2026.
Get free HealthEquity email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $92.28
- Average price target
- $119.33
- High price target
- $142.00
- Low price target
- $105.00
- Low target gap
- +13.8%
- Target upside
- +29.3%
- High target gap
- +53.9%
- Target range width
- 40.1%
- Consensus rating
- Strong Buy
- Analysts
- 15
- Evidence date
- October 7, 2026
- Valid through
- October 14, 2026
Explore related company data
Read the frequently asked questions.
What is HealthEquity's average price target?
HealthEquity's verified average price target is $119.33. The target range is $105.00 to $142.00.
How far are HealthEquity's low and high targets from the recorded price?
The low target implies +13.8%, while the high target implies +53.9%.
How many analysts are included in HealthEquity's consensus?
The verified consensus includes 15 analysts.
How is HealthEquity's target upside or downside calculated?
The average target of $119.33 is divided by the recorded price of $92.28, then one is subtracted to produce +29.3%. This does not guarantee a future return.
When was HealthEquity's analyst forecast verified?
The data was verified on 2026-10-07. The dataset is valid through 2026-10-14.